Q9003 HCPCS Level II code: Counseling, group, by chaplain services
Q9003 is the HCPCS code for “Counseling, group, by chaplain services” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
Q9003Counseling, group, by chaplain services
Short description: Chaplain counsel group
HCPCS · United States
Medicare details
The indicators CMS publishes with Q9003 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Value not established
- Type of service
- Consultation
- BETOS category
- Undefined codes
- Added
- Oct 1, 2020
Where Q9003 sits
- 1Q codesTemporary codes
- 2Active code Q9003Counseling, group, by chaplain services
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code Q9003 mean?
Q9003 is the HCPCS code for “Counseling, group, by chaplain services” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover Q9003?
CMS lists Q9003’s Medicare coverage as “Carrier judgment” and its pricing as “Value not established”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q9003
All Q codesQ5170Injection, aflibercept-boav (eydenzelt), biosimilar, 1 mgQ5171Injection, denosumab-mobz (boncresa), biosimilar, 1 mgQ5172Injection, filgrastim-laha (filkri), biosimilar, 1 microgramQ5173Injection, denosumab-adet (ponlimsi), biosimilar, 1 mgQ9001Assessment by chaplain servicesQ9002Counseling, individual, by chaplain servicesQ9004Department of veterans affairs whole health partner servicesQ9950Injection, sulfur hexafluoride lipid microspheres, per mlQ9951Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per mlQ9953Injection, iron-based magnetic resonance contrast agent, per mlQ9954Oral magnetic resonance contrast agent, per 100 mlQ9955Injection, perflexane lipid microspheres, per ml